Global Drug-Eluting Coating Market Research Report 2016

Global Drug-Eluting Coating Market Research Report 2016

1 Drug-Eluting Coating Market Overview

1.1 Product Overview and Scope of Drug-Eluting Coating

1.2 Drug-Eluting Coating Segment by Type

1.2.1 Global Production Market Share of Drug-Eluting Coating by Type in 2015

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 Drug-Eluting Coating Segment by Application

1.3.1 Drug-Eluting Coating Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Drug-Eluting Coating Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Drug-Eluting Coating (2011-2021)

2 Global Drug-Eluting Coating Market Competition by Manufacturers

2.1 Global Drug-Eluting Coating Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 Global Drug-Eluting Coating Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Drug-Eluting Coating Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Drug-Eluting Coating Manufacturing Base Distribution, Sales Area and Product Type

2.5 Drug-Eluting Coating Market Competitive Situation and Trends

2.5.1 Drug-Eluting Coating Market Concentration Rate

2.5.2 Drug-Eluting Coating Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Drug-Eluting Coating Capacity, Production, Revenue (Value) by Region (2011-2016)

3.1 Global Drug-Eluting Coating Capacity and Market Share by Region (2011-2016)

3.2 Global Drug-Eluting Coating Production and Market Share by Region (2011-2016)

3.3 Global Drug-Eluting Coating Revenue (Value) and Market Share by Region (2011-2016)

3.4 Global Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.5 North America Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.6 Europe Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.7 China Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Japan Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.9 Southeast Asia Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.10 India Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Drug-Eluting Coating Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Drug-Eluting Coating Consumption by Regions (2011-2016)

4.2 North America Drug-Eluting Coating Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Drug-Eluting Coating Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Drug-Eluting Coating Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Drug-Eluting Coating Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Drug-Eluting Coating Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Drug-Eluting Coating Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Drug-Eluting Coating Production, Revenue (Value), Price Trend by Type

5.1 Global Drug-Eluting Coating Production and Market Share by Type (2011-2016)

5.2 Global Drug-Eluting Coating Revenue and Market Share by Type (2011-2016)

5.3 Global Drug-Eluting Coating Price by Type (2011-2016)

5.4 Global Drug-Eluting Coating Production Growth by Type (2011-2016)

6 Global Drug-Eluting Coating Market Analysis by Application

6.1 Global Drug-Eluting Coating Consumption and Market Share by Application (2011-2016)

6.2 Global Drug-Eluting Coating Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Drug-Eluting Coating Manufacturers Profiles/Analysis

7.1 Armoloy of Connecticut, Inc. (US)

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Drug-Eluting Coating Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Armoloy of Connecticut, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 AST Products, Inc. (US)

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Drug-Eluting Coating Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 AST Products, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Biocoat, Inc. (US)

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Drug-Eluting Coating Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Biocoat, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 Biophan Technologies, Inc. (US)

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Drug-Eluting Coating Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Biophan Technologies, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Carmeda AB (Sweden)

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Drug-Eluting Coating Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Carmeda AB (Sweden) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Covalon Technologies Ltd. (Canada)

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Drug-Eluting Coating Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Covalon Technologies Ltd. (Canada) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Hemoteq AG (Germany)

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Drug-Eluting Coating Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Hemoteq AG (Germany) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Hydromer, Inc. (US)

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Drug-Eluting Coating Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Hydromer, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 N2 Biomedical (US)

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Drug-Eluting Coating Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 N2 Biomedical (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 Nanocopoeia, Inc. (US)

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Drug-Eluting Coating Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 Nanocopoeia, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

8 Drug-Eluting Coating Manufacturing Cost Analysis

8.1 Drug-Eluting Coating Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Drug-Eluting Coating

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Drug-Eluting Coating Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Drug-Eluting Coating Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Drug-Eluting Coating Market Forecast (2016-2021)

12.1 Global Drug-Eluting Coating Capacity, Production, Revenue Forecast (2016-2021)

12.2 Global Drug-Eluting Coating Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Drug-Eluting Coating Production Forecast by Type (2016-2021)

12.4 Global Drug-Eluting Coating Consumption Forecast by Application (2016-2021)

12.5 Drug-Eluting Coating Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Drug-Eluting Coating

Figure Global Production Market Share of Drug-Eluting Coating by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Drug-Eluting Coating Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America Drug-Eluting Coating Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Drug-Eluting Coating Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Drug-Eluting Coating Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Drug-Eluting Coating Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Drug-Eluting Coating Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Drug-Eluting Coating Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Drug-Eluting Coating Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Drug-Eluting Coating Capacity of Key Manufacturers (2015 and 2016)

Table Global Drug-Eluting Coating Capacity Market Share by Manufacturers (2015 and 2016)

Figure Global Drug-Eluting Coating Capacity of Key Manufacturers in 2015

Figure Global Drug-Eluting Coating Capacity of Key Manufacturers in 2016

Table Global Drug-Eluting Coating Production of Key Manufacturers (2015 and 2016)

Table Global Drug-Eluting Coating Production Share by Manufacturers (2015 and 2016)

Figure 2015 Drug-Eluting Coating Production Share by Manufacturers

Figure 2016 Drug-Eluting Coating Production Share by Manufacturers

Table Global Drug-Eluting Coating Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Drug-Eluting Coating Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Drug-Eluting Coating Revenue Share by Manufacturers

Table 2016 Global Drug-Eluting Coating Revenue Share by Manufacturers

Table Global Market Drug-Eluting Coating Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Drug-Eluting Coating Average Price of Key Manufacturers in 2015

Table Manufacturers Drug-Eluting Coating Manufacturing Base Distribution and Sales Area

Table Manufacturers Drug-Eluting Coating Product Type

Figure Drug-Eluting Coating Market Share of Top 3 Manufacturers

Figure Drug-Eluting Coating Market Share of Top 5 Manufacturers

Table Global Drug-Eluting Coating Capacity by Regions (2011-2016)

Figure Global Drug-Eluting Coating Capacity Market Share by Regions (2011-2016)

Figure Global Drug-Eluting Coating Capacity Market Share by Regions (2011-2016)

Figure 2015 Global Drug-Eluting Coating Capacity Market Share by Regions

Table Global Drug-Eluting Coating Production by Regions (2011-2016)

Figure Global Drug-Eluting Coating Production and Market Share by Regions (2011-2016)

Figure Global Drug-Eluting Coating Production Market Share by Regions (2011-2016)

Figure 2015 Global Drug-Eluting Coating Production Market Share by Regions

Table Global Drug-Eluting Coating Revenue by Regions (2011-2016)

Table Global Drug-Eluting Coating Revenue Market Share by Regions (2011-2016)

Table 2015 Global Drug-Eluting Coating Revenue Market Share by Regions

Table Global Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table China Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table India Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Drug-Eluting Coating Consumption Market by Regions (2011-2016)

Table Global Drug-Eluting Coating Consumption Market Share by Regions (2011-2016)

Figure Global Drug-Eluting Coating Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Drug-Eluting Coating Consumption Market Share by Regions

Table North America Drug-Eluting Coating Production, Consumption, Import & Export (2011-2016)

Table Europe Drug-Eluting Coating Production, Consumption, Import & Export (2011-2016)

Table China Drug-Eluting Coating Production, Consumption, Import & Export (2011-2016)

Table Japan Drug-Eluting Coating Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Drug-Eluting Coating Production, Consumption, Import & Export (2011-2016)

Table India Drug-Eluting Coating Production, Consumption, Import & Export (2011-2016)

Table Global Drug-Eluting Coating Production by Type (2011-2016)

Table Global Drug-Eluting Coating Production Share by Type (2011-2016)

Figure Production Market Share of Drug-Eluting Coating by Type (2011-2016)

Figure 2015 Production Market Share of Drug-Eluting Coating by Type

Table Global Drug-Eluting Coating Revenue by Type (2011-2016)

Table Global Drug-Eluting Coating Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Drug-Eluting Coating by Type (2011-2016)

Figure 2015 Revenue Market Share of Drug-Eluting Coating by Type

Table Global Drug-Eluting Coating Price by Type (2011-2016)

Figure Global Drug-Eluting Coating Production Growth by Type (2011-2016)

Table Global Drug-Eluting Coating Consumption by Application (2011-2016)

Table Global Drug-Eluting Coating Consumption Market Share by Application (2011-2016)

Figure Global Drug-Eluting Coating Consumption Market Share by Application in 2015

Table Global Drug-Eluting Coating Consumption Growth Rate by Application (2011-2016)

Figure Global Drug-Eluting Coating Consumption Growth Rate by Application (2011-2016)

Table Armoloy of Connecticut, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Armoloy of Connecticut, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Armoloy of Connecticut, Inc. (US) Drug-Eluting Coating Market Share (2011-2016)

Table AST Products, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AST Products, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure AST Products, Inc. (US) Drug-Eluting Coating Market Share (2011-2016)

Table Biocoat, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Biocoat, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Biocoat, Inc. (US) Drug-Eluting Coating Market Share (2011-2016)

Table Biophan Technologies, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Biophan Technologies, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Biophan Technologies, Inc. (US) Drug-Eluting Coating Market Share (2011-2016)

Table Carmeda AB (Sweden) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Carmeda AB (Sweden) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Carmeda AB (Sweden) Drug-Eluting Coating Market Share (2011-2016)

Table Covalon Technologies Ltd. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Covalon Technologies Ltd. (Canada) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Covalon Technologies Ltd. (Canada) Drug-Eluting Coating Market Share (2011-2016)

Table Hemoteq AG (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Hemoteq AG (Germany) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Hemoteq AG (Germany) Drug-Eluting Coating Market Share (2011-2016)

Table Hydromer, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Hydromer, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Hydromer, Inc. (US) Drug-Eluting Coating Market Share (2011-2016)

Table N2 Biomedical (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table N2 Biomedical (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure N2 Biomedical (US) Drug-Eluting Coating Market Share (2011-2016)

Table Nanocopoeia, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Nanocopoeia, Inc. (US) Drug-Eluting Coating Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Nanocopoeia, Inc. (US) Drug-Eluting Coating Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Drug-Eluting Coating

Figure Manufacturing Process Analysis of Drug-Eluting Coating

Figure Drug-Eluting Coating Industrial Chain Analysis

Table Raw Materials Sources of Drug-Eluting Coating Major Manufacturers in 2015

Table Major Buyers of Drug-Eluting Coating

Table Distributors/Traders List

Figure Global Drug-Eluting Coating Capacity, Production and Growth Rate Forecast (2016-2021)

Figure Global Drug-Eluting Coating Revenue and Growth Rate Forecast (2016-2021)

Table Global Drug-Eluting Coating Production Forecast by Regions (2016-2021)

Table Global Drug-Eluting Coating Consumption Forecast by Regions (2016-2021)

Table Global Drug-Eluting Coating Production Forecast by Type (2016-2021)

Table Global Drug-Eluting Coating Consumption Forecast by Application (2016-2021)